– USA, CA – Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of independent director Beckie Robertson as Chair of the Board of Directors, succeeding Kim Blickenstaff, who will remain on the Board.
About Rebecca Robertson
Rebecca Robertson has an impressive track record of helping medical device companies scale in her roles as an engineer, entrepreneur, corporate executive, and board member. She is a founder and General Partner at Versant Ventures where she has specialized in investing in medical devices and diagnostics since 1999. In addition, through Longridge Business Advisors, she has provided business advisory services and board services since April 2017. Before Versant, she served as SVP at Chiron Diagnostics, a division of Chiron Corporation, where she was responsible for the critical care business unit and leading the division’s business development efforts. Before joining Chiron, Ms. Robertson was a co-founder and VP at Egis, a consumer products company, and held senior management positions in operations and finance at Lifescan, a Johnson & Johnson Company.
“I am honored to be named Chair and am committed to maximizing the opportunities we have at Tandem,” said Ms. Robertson. “Tandem continues to deliver life-changing solutions to people around the world and has a compelling pipeline of products in development that offer near and long-term growth potential. I believe our technology can change the face of therapy for people with diabetes and I’m excited to be part of what comes next.”
Ms. Robertson holds a BS in Chemical Engineering from Cornell University.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t: slim X2 insulin pump with Control-IQ technology.
For more information: https://www.tandemdiabetes.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.